Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 512

Marqeta makes off with $150m

An undisclosed investor provided the funding at a $4.3bn valuation, Marqeta having previously raised nearly $370m from backers including Commerzbank, Visa and CreditEase.

May 29, 2020

Cisco sets aside $1bn for ThousandEyes acquisition

Cisco intends to purchase the network analytics software producer, which had raised more than $110m from investors including GV and Salesforce Ventures, for a reported $1bn.

May 29, 2020

Pie Insurance picks out $127m

Existing investor Sirius was among the investors as the worker's compensation provider received a total of $127m, with $100m allocated to the launch of an affiliate called Pie Carrier.

May 29, 2020

Vision Fund prepares for job cuts

Vision Fund is reportedly set to reduce the size of a 500-strong team by about 10% in the wake of some $18bn in losses over the past year.

May 29, 2020

Aircall rings up $65m

The call management platform developer has completed a series C round led by DTCP that also featured Swisscom Ventures.

May 29, 2020

DefinedCrowd attracts series B funding

EDP Ventures and Semapa Next took part in a $50.5m series B round for the AI verification data provider, which counts Amazon, Sony and Mastercard as earlier investors.

May 29, 2020

Ascus Biosciences gets fed $46m

Cavallo Ventures contributed to a series B round for the microbial animal feed producer that will fund product development and recruitment.

May 29, 2020

Daily deal net: May 28, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

May 28, 2020

AbCellera accelerates with $105m

University of Minnesota has invested in UBC spinout AbCellera's series B round that also included Eli Lilly.

May 28, 2020

Pliant places IPO terms

Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.

May 28, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here